Table 1.
Overview of dural sinus stenting cases: major reported symptoms and their outcomes
| First author | Cases, f/m | Headache |
Papilledema |
Visual problems |
Follow-up (mean), months | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| resolved/improved | no Δ | worse | resolved/improved | no Δ | worse | resolved/improved | no Δ | worse | |||
| Ahmed [12], 2011 | 47/5 | 40 | 3 | 0 | 46 | 0 | 0 | 32 | 11 | 0 | 2–108 (24) |
| Albuquerque [13], 2011 | 15/3 | 16 | 1 | 1 | 2–40 (20) | ||||||
| Arac [20], 2009 | 1/0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 2 |
| Bussière [14], 2010 | 10/0 | 10 | 0 | 0 | 9 | 0 | 0 | 4 | 0 | 0 | 3–60 |
| Donnet [9], 2008 | 8/2 | 8 | 2 | 0 | 10 | 0 | 0 | 6 | 4 | 0 | 6–36 |
| Fields [6], 2012 | 15/0 | 10 | 4 | 1 | 15 | 0 | 0 | 7 | 2 | 3 | 3–44 (9) |
| He [10], 2012 | 24 | 16 | 8 | 0 | 10 | 14 | 0 | 13 | 11 | 0 | 2–19 |
| Higgins [5], 2003 | 12/0 | 7 | 5 | 0 | 5 | 3 | 0 | 2–26 | |||
| Higgins [4], 2002 | 1/0 | 1 | 0 | 0 | 1 | 0 | 0 | 12 | |||
| Khalia [21], 2010a | 18/4 | 18 | 4 | 0 | 16 | 0 | 0 | 13 | 7 | 0 | 3–24 |
| Kumpe [7], 2012 | 12/6 | 10 | 2 | 0 | 16 | 2 | 0 | 18 | 0 | 0 | 11–136 (44) |
| Lazzaro [19], 2012 | 3/0 | 2 | 1 | 0 | 3 | 0 | 0 | 3 | 0 | 0 | 1–21 (11) |
| Ogungbo [15], 2003 | 1/0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 12 |
| Owler [18], 2003 | 3/1 | 4 | 0 | 0 | 2 | 1 | 0 | 4 | 0 | 0 | 5–12 |
| Paquet [17], 2008 | 1/0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | |
| Rajpal [16], 2005 | 0/1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 6 |
| Radvany [8], 2013 | 11/1 | 7 | 5 | 0 | 11 | 1 | 0 | 11 | 0 | 1 | 9–36 (16) |
| Teleb [23], 2012 | 1/0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 6 |
| Zheng [22], 2010 | 1/0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 3 |
Δ = Change.
a
Case series presented in abstract form at the 2010 Annual Meeting of the American Academy of Neurology, Poster P05.284.